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Abstract 
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of the motor system with recognised extra-motor 
and cognitive involvement. This cross-sectional study examined ALS patients’ performance on measures requiring social 
inference, and determined the relationship between such changes and variations in mood, behaviour, personality, 
empathy and executive function.  Fifty-five ALS patients and 49 healthy controls were compared on tasks measuring 
social cognition and executive function. ALS patients also completed measures examining mood, behaviour and 
personality. Regression analyses explored the contribution of executive function, mood, behaviour and personality to 
social cognition scores within the ALS sample. A between-group MANOVA revealed that, the ALS group was impaired 
relative to controls on two composite scores for social cognition and executive function. Patients also performed worse 
on individual tests of executive function measuring cognitive flexibility, response inhibition and concept formation, and 
on individual aspects of social cognition assessing the attribution of emotional and mental states. Regression analyses 
indicated that ALS-related executive dysfunction was the main predictor of social cognition performance, above and 
beyond demographic variables, behaviour, mood and personality. On at least some aspects of social cognition, impaired 
performance in ALS appears to be secondary to executive dysfunction. The profile of cognitive impairment in ALS 
supports a cognitive continuum between ALS and frontotemporal dementia. 
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Introduction 
Amyotrophic lateral sclerosis (ALS) is the most prevalent form of motor neuron disease (MND). Approximately 10 - 
15% of ALS patients fulfil criteria for frontotemporal dementia (FTD). However, non-demented ALS patients may show 
milder cognitive and behavioural symptoms [1, 2], indicating a possible cognitive continuum between ALS and FTD that 
might correspond to cerebral abnormalities common to both disorders [3]. ALS cognitive impairment is characterized by 
executive dysfunction [4], with growing evidence for language involvement [5]. Behavioural changes, including 
increased apathy and disinhibition have been noted [6], while modest evidence for ALS-specific personality traits exists 
[7]. Recently there has been interest in potential impairments in social cognition in ALS. Social cognition refers to 
cognitive processes that subserve the encoding and decoding of socially salient information, such as the emotions and 
intentions of others [8]. Converging evidence suggests that these processes are supported by a frontostriatal network [9], 
the disruption of which may underlie behaviour and personality changes associated with several neurodegenerative 
conditions [10]. The investigation of social cognition in ALS has focussed on basic emotion recognition and Theory of 
Mind (ToM), the ability to infer others’ mental and emotional states so as to understand and predict their behaviour [11]. 
Deficits in the recognition of emotion from faces have been reported in ALS patients [2, 12, 13], albeit not consistently 
[14, 15], with one study suggesting that such impairments only emerge with FTD-comorbidity [16]. These studies have 
used a range of different measures and impairment criteria, across typically small samples (n < 35), sometimes including 
patients with FTD [12], all of which may contribute to the variance in findings reported. The investigation of ToM in 
ALS has relied exclusively on cartoons and written or video vignettes [see [17] for review]. Relative to healthy controls,  
people with ALS have shown difficulty with describing the intentions and feelings of characters [15, 18, 19], identifying 
and explaining social faux pas [20] and estimating characters’ preferences for objects based on their eye gaze direction 
[13, 21].  
 
Whether the reported deficits in social cognition are related to wider cognitive-behavioural impairment is unclear. 
Moderate correlations between behavioural scores and social cognition tasks have been found in some studies [13, 21]; 
but in general, behaviour is not commonly assessed alongside these measures. More frequently, social cognition 
performance has been associated with executive function indices [18, 20, 22], suggesting that executive dysfunction may 
partially underlie the observed impairments. Nonetheless, the respective contributions of behaviour, personality and 
executive function to ALS social cognition impairment remain unclear.  We therefore sought to investigate the profile 
and extent of social cognition changes in the largest sample reported to date of patients with ALS without FTD, using an 
extensive battery of executive function and social cognition tasks. We also explored the relationship between social 
cognition in ALS and variations in executive function, everyday frontally-mediated behaviour, mood and personality. 
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The hypotheses for the study were as follows: (i) relative to controls, patients with non-demented ALS will show poorer 
performance on separate composites and individual tests of executive function and social cognition and (ii) executive 
function will be the main predictor of performance on a composite of social cognition, with smaller contributions from 
behaviour, mood and personality (above and beyond patients’ age and years of education). 
 
Methods 
Participants 
Fifty-five ALS patients, meeting criteria for definite, clinically definite, probable or laboratory-supported probable ALS 
[23], without co-morbid FTD were recruited from MND Care and Research Centres across London, Cambridge and Kent 
in the UK. Forty-nine age-, gender- and education-matched healthy control (HC) participants were recruited through a 
volunteer database. Participants were recruited between January 2011 and May 2013. Exclusion criteria for all 
participants were: a diagnosis of another neurological or a psychiatric condition or diabetes; aged  > 75 years; a first 
language other than English; a clinical diagnosis of dementia and respiratory insufficiency, as determined by the patients’ 
clinical team, a forced vital capacity < 70% (where available) and a score > 10 on the Epworth Sleepiness Scale [24]. 
 
Cognitive and behavioural measures 
Premorbid and current IQ were estimated using the Wechsler Test of Adult Reading [25] and the Wechsler Abbreviated 
Scale of Intelligence [26], respectively. The modified Hospital Anxiety and Depression Scale (HADS) [27] measured 
symptoms of anxiety and depression. In the patients, functional abilities were assessed using the Revised Amyotrophic 
Lateral Sclerosis Functional Rating Scale (ALSFRS-R) [28].  
Social cognition was assessed using a variety of measures used in previous studies of ALS but not together [13, 15, 18]: 
the Reading the Mind in the Eyes task (RME) [29]; three subtests of The Awareness of Social Inference Test (TASIT) 
[30] and three subtests of the Happé Cartoon and Written Scenarios tasks [31]. Executive function was assessed using the 
sorting and description trials of the Card Sorting Task of the Delis-Kaplan Executive Function Test (D-KEFS) [32]; the 
‘S’ and ‘C’ trials of the modified Verbal Fluency Index (VFI) [33] and number of errors on the Brixton Test [34]. Testing 
also included one language and one memory test (see Tables S1 and S2, Online Resource 1). Measures used to assess 
behaviour, empathy, emotional lability and personality were: the Frontal Systems Behaviour Scale (FrSBe) [35]; the 
Interpersonal Reactivity Index (IRI) [36]; the ALS-specific Emotional Lability Questionnaire (ELQ) [37] and the NEO-
Five-Factor-Inventory (NEOFFI) [38], respectively. Details of the specific components measured for each test are 
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provided in Table 1. All tests and measures were untimed except for the VFI which contains a control condition to 
account for writing speed. For the D-KEFS sorting task, administration was discontinued when the participant had 
completed 10 attempted sorts, attained all the target sorts or indicated that he or she could not generate any sorts after a 
prompt.  
 
Statistical analysis 
To reduce the likelihood of making Type 1 errors through multiple comparisons of individual test scores, composites for 
executive function and social cognition were created. Test scores for individual ALS patients were first standardised on 
the control group by subtracting the control group mean score from each patient’s score on that test and dividing the 
difference by the corresponding control group standard deviation (SD). Where necessary, scores were reflected so that 
higher scores all indicated worse performance. The standardised scores within each domain were then summed and 
divided by the number of component measures to give and Executive composite and Social Cognition composite. Where 
there were missing data (see Table 3), the composite was divided by the number of tests completed. Composite scores 
showed satisfactory internal consistency (Executive: α = 0.78; Social Cognition: α = 0.83). Between-group comparisons 
were undertaken using t-tests or multivariate analysis of variance (MANOVA). Pearson’s correlations and multiple 
regression (MR) analyses were used to examine the relationships between variables. Outliers were identified using the 
Median Absolute Deviation Method [39] and transformed to reduce their impact on analyses. Univariate normality was 
assessed using the D’Agostino–Pearson Omnibus Test [40], while multivariate normality was assessed using the Shapiro-
Wilks Multivariate test [41], available in R Version 3.0.1 [42]. Non-normal distributions, including the composite scores, 
were transformed using Naperian log transformation. Statistical significance was set at p < 0.05. Between-group 
differences were also presented in terms of effect sizes: either Cohen’s d, partial eta squared (ηρ²) and Cramer’s V. 
Between-group comparisons, percentile and regression analyses were performed using IBM SPSS Version 21.0 [43].  
  
Results  
Demographic and clinical characteristics 
The ALS and HC groups comprised 15 (27.4%) and 15 (30.6%) females, respectively. There was no difference between 
the ALS and HC groups with respect to gender [χ2(1) = 0.14, p = 0.71, Cramer’s V = 0.04]; age [t(102) = -0.14, p = 0.89, 
d = 0.03]; years of education [t(100.13) = -0.002, p = 0.10, d = 0.00]; current IQ [z = -1.06, p = 0.29, r = -0.10] or 
estimated premorbid IQ [z = -0.95, p = 0.34, r = -0.14]; the HADS Total score [z = -0.69, p = 0.49, r = -0.07] or the 
depression [z = -1.58, p = 0.12, r = -0.15] or anxiety [z = -0.27, p = 0.79, r = -0.03] subscales (Table 2). The mean patient 
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ALSFRS-R score at the time of assessment was 34.05 (SD 7.80). Approximately 76% of the patients had limb-onset and 
approximately 24% had bulbar-onset disease. The average time since onset of symptoms was 31.8 months (SD 18.5), 
with a median delay from symptom onset to diagnosis of 12.0 months (IQR 8.0-21.0). 
 
Cognitive function and behaviour 
Figure 1 shows the mean composite scores for the patient and control groups. A one-way MANOVA revealed an overall 
group difference [F(2,101) = 4.68, p = 0.01, Wilks’ Lambda = 0.92, ηρ² = 0.09], with univariate contrasts revealing that 
the patients were more impaired on both the Executive composite [F(1,102) = 8.6, p = 0.004, ηρ² = 0.08] and the Social 
Cognition composite [F(1,102) = 5.53, p = 0.02, ηρ² = 0.05]. 
 
To aid interpretation of these overall effects, performance on individual executive and social cognition tests was explored 
using two-tailed t-tests (Table 3). Patients performed less well than HCs on the D-KEFS sorting errors [t(100) = -2.7, p = 
0.009, d = 0.55]; D-KEFS description errors [t(100) = -3.2, p = 0.002, d = 0.63] and the VFI ‘C’ trial [t(86.9) = -2.2, p = 
0.03, d = 0.35]. A trend was found for the VFI ‘S’ trial [t(93.5) = -1.8, p = 0.08, d = 0.42]. No group difference was 
found for Brixton errors.  For social cognition, patients performed worse than HCs on the Happé Cartoon Single 
Inference test (C-Sin) [t(91) = -4.87, p < 0.001, d = 1.01], Happé Cartoon Pairs Inference test errors (C-Pairs) [t(91) = -
3.2, p = 0.002, d = 0.67] and the Happé Written Scenarios test  (Scenarios) [t(81) = -2.82, p = 0.006, d = 0.62]. No 
differences were found for any of the TASIT subtest scores or the RME errors score.  Figure 2 shows the standardised 
scores of the ALS group (scores all zero for the HCs) for the different tasks. Table 3 displays the proportion of ALS 
patients performing at or below the 5th percentile of the control group on the composites and cognitive tasks. Table 3 also 
displays the proportion of patients meeting criteria for clinically relevant behaviour (FrSBe), ‘extremely high’ or 
‘extremely low’ levels of personality traits (NEOF-FFI) and whose self-ratings were at or below the 5th percentile of the 
control group for empathy (IRI) and emotional lability (ELQ). 
 
The number of patients meeting current criteria for cognitive impairment [44], impairments on two or more tests of 
executive function, was 4/55 (7.3 %). The number of patients meeting criteria for behavioural impairment, defined here 
as showing clinically relevant behaviour on two or more domains of the FrSBe, was 15/51 (29.4 %). By extension, and 
for exploratory purposes, the number of patients showing two or more impairments on the social cognition tasks and 
thereby meeting criteria for social cognition impairment was 6/55 (10.9 %). The individual cognitive and behavioural 
profiles of these six patients are displayed in Table 4. Two of the six patients also qualified for cognitive impairment 
(≥2+ impairments on executive function tasks). One of the six patients qualified for behavioural impairment (≥2+ 
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impairments on FrSBe). That same patient reported that their level of empathic concern was lower than the 5 th percentiles 
of the control group.  
 
Predictors of social cognition in ALS patients  
Predictors of social cognition function within the ALS group were investigated using Executive and Social Cognition 
composite scores restandardised using the ALS group’s means and SDs so as to investigate the relationship between 
social cognition and executive function within the ALS sample [Executive: α = 0.80; Social Cognition: α = 0.88]. This 
approach has been used in other ALS studies [5].  Possible predictors (demographic, disease, mood, personality, 
behaviour and Executive function scores) were chosen on the basis of previous findings from ALS studies [2, 4-7, 12-16, 
18-22] and statistical criteria, such as a linear relationship with the Social Cognition composite. Mean scores for the 
subscales of the FrSBe, NEOFFI and IRI, relevant to these analyses, are reported for reference in Table 3.  
 
Bivariate correlational analyses were first conducted to identify significant relationships between potential predictor 
variables and the Social Cognition composite (p < 0.05, see Table S3, Online Resource 1). Significant associations with 
the Social Cognition composite were found for: the Executive function composite [r = 0.61, p <0.001]; FrSBe Total [r = 
0.35, p = 0.01]; HADS Total [r = -0.27, p = 0.05]; NEOFFI Openness T-score [r = - 0.32, p = 0.01]; age in years [r = 
0.44, p = 0.001] and years of formal education [r = -0.29, p =0.03]. These variables were entered into a multiple 
regression with the Social Cognition composite as the dependent variable. To better assess the contribution of executive 
functioning, the independent variables were entered in a hierarchical design in the following stages: Stage 1: Age and 
education (control variables); Stage 2: FrSBe Total, HADS Total and NEOFFI Openness T-score; Stage 3: Executive 
Function Composite (See Table S4, Online Resource 1). The final model, with all predictor variables entered into the 
equation, predicted 44.5% of the variance in the Social Cognition composite. In the final model the executive function 
composite was the only predictor [standardised β = 0.49, 95% CI (0.24; 0.72), t(46) = 3.98, p < 0.001]. 
 
Discussion 
This study used an extensive battery of social cognition measures, alongside standardised measures of executive 
function, behaviour and personality in a relatively large sample of people with ALS without dementia. Even though as a 
group there was evidence of only mild executive dysfunction on formal tests, the results suggest a strong association 
between executive function and social cognition, with 45% shared variance on the ALS group composite scores. As a 
group, those with ALS performed worse than controls matched for age, education, gender and IQ on a composite 
measure of social cognition, with impairment on individual tasks that required the attribution of complex thoughts, 
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feelings and beliefs to characters in cartoons and social stories (Happé tasks). In contrast, other aspects of social 
cognition were intact. The patient group was unimpaired on a measure of empathy, the ability to identify emotion in the 
faces of others, or to identify and interpret sarcastic exchanges between actors simulating everyday social interaction on 
the TASIT. The finding that group effects were elicited on the Happé task and not the TASIT social inference subtasks 
might be due to the greater complexity of the former measure. While both tasks seemingly require similar processes, the 
TASIT places less demands on the integration of abstract information and no effortful expression of this integration into 
a coherent narrative (the TASIT requires only a forced-choice response). The TASIT thus places fewer demands on 
executive function, a mechanism suggested to underlie previously reported deficits on the Happé tasks in ALS and FTD 
[18, 45]. The current study failed to replicate the ALS group deficits reported previously on the TASIT [15]. At the 
individual level, some participants with ALS showed difficulty with the sarcastic exchanges, particularly on the SI-M 
component of the task where additional contextual cues, such as a visual cue or a scene prologue, were not available to 
aid interpretation (see Table 3). These results underscore the heterogeneity of performance within ALS samples on social 
cognition measures and the importance of replicating findings with adequate representative samples. Previous reports of 
emotion identification deficits in ALS have been variable [17]. In the current sample, impairments on the RME and the 
emotion recognition condition of the TASIT were noted when individual patient performance was compared with the 
control group (Table 3). These deficits might reflect a more severe manifestation of social cognitive impairment; possibly 
a harbinger for the progression of ALS-FTD [16].  
 
Cerebral atrophy in ALS may extend beyond the motor cortices to the prefrontal and temporal regions, areas implicated 
in FTD [3]. In the behavioural variant of FTD (bvFTD), overt behavioural and personality changes represent hallmarks 
of the disease [46] and may reflect a breakdown in higher order social cognitive processes, such as emotion attribution 
and the understanding of social situations. Such change in turn may correspond to cortical atrophy along a frontotemporal 
gradient [47]. The finding of an overall impairment on the Social Cognition composite in the current ALS sample, as 
with previous reports, therefore reinforces the notion of a cognitive overlap between ALS and FTD, possibly implicating 
common neuropathology. For example, impairment on the Happé social situation tasks, which require the inference of 
intentions, beliefs and emotions from characters in cartoons or social stories is found in ALS (here and [18]) and in FTD 
[45], although as noted above, this may reflect executive impairment rather than an underlying deficit in social cognition. 
Some differences, however, are apparent. As noted above, unlike in FTD [48], the ALS group in the present study did not 
show impaired recognition of facial emotion. Neither did they show difficulty in identifying sarcastic exchanges between 
actors simulating everyday social interaction on the TASIT. Such social cognition impairments may require the more 
developed pathology seen in FTD, and be less characteristic of pure ALS.   
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Although the results of the regression analysis indicated a significant association between executive function and social 
cognition, there was no evidence of a significant independent contribution of mood, personality or other behavioural 
features of ALS. Further, of the six patients who were impaired on two or more tests of social cognition, only one met 
criteria for behavioural impairment and reported reduced empathy relative to controls.  While this may indicate that such 
factors are unrelated to social cognition, the result should not necessarily be generalised to patients with ALS showing 
more marked mood, personality or behavioural change. Moreover, the current study used patients’ self-ratings to measure 
these domains and thus the possibility of reduced insight into their own neuropsychiatric change cannot be excluded. 
This caveat potentially limits the inferences drawn regarding the contribution of patients’ neuropsychiatric symptoms to 
their performance on the social cognition tasks. The only personality domain to correlate significantly with the Social 
Cognition composite was the NEO-FFI Openness T-score, with less Openness associated with worse social cognition. 
People who score low on this trait typically feel emotion less intensely than others and are less attentive to forms of 
experience, such as fantasy and intellectual curiosity [49]. The presence of this relationship is therefore meaningful.     
 
Executive functioning alone was sufficient to predict a significant proportion of the variability in the Social Cognition 
composite; however, a notable proportion (55%) remained unexplained. Future research is required to identify additional 
sources of variance, although some error variance will always be present. For example, aspects of higher level language 
functioning may contribute to variability in social cognition in ALS. Performance on social cognition measures and the 
non-literal aspects of language have been indicated in neurological patients [50].  In turn, the processing of non-literal 
speech has been correlated with executive function and semantic knowledge in bvFTD patients [51] and syntactic 
competence in aphasic FTD patients [52]. There is increasing recognition of language involvement in ALS, including 
semantic processing and syntactic comprehension, in non-demented patients with ALS [5, 53], which may co-occur or be 
independent of executive function [5]. Future research should investigate whether a complex relationship between 
executive function, language processing and social cognition can explain performance on social cognition measures by 
people with ALS.  
 
The clinical relevance of the cognitive deficits shown by the current ALS sample deserves consideration. Patients 
exhibiting executive deficits may potentially have difficulties managing financial affairs, planning for future events or 
arriving at decisions regarding their clinical care. Early screening for cognitive impairment in ALS, would aid the 
direction of care strategies. While overall the ALS patients showed no difficulty with emotion recognition, they did show 
difficulty interpreting the intentions and beliefs of cartoon and story characters. This highlights the possibility that people 
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with ALS may respond appropriately to other people’s emotions, but be less able to anticipate or infer the thoughts or 
intentions of those around them. This can place strain on the patient’s interpersonal relationships which become more 
important as their dependency on others increases with their functional decline. The implications for and education of the 
caregiver with regards to possible interpersonal changes in the patient should be considered in clinical consultations with 
ALS families. Clinic screening assessments may, therefore, also usefully include aspects of social cognition [53].   
 
This study is not without limitations. The focus of the assessment was on social cognition and executive function, with 
only a brief assessment of memory and basic aspects of language function (see Tables S1 and S2, Online Resource 1). 
The use of composite scores, while necessary to avoid the possibility of increased family-wise error rate, may have 
masked associations for individual measures. Likewise, the z-score method used for creating the composite scores 
assumes that each task is equally difficult and that each component carries equal weighting in the overall score, which 
may not be the case.  As mentioned, the reliance on patients’ self-ratings without proxy-ratings of empathy, behaviour 
and personality may have underestimated the nature and severity of neuropsychiatric changes in the sample. The lack of 
objective measures to determine respiratory insufficiency in patients leaves open the possibility that some of the 
cognitive deficits reported here may have been influenced by the inclusion of patients who themselves or their clinician 
were unaware of subtle decrements in respiratory functioning. Nonetheless, the current study revealed a profile of FTD-
like cognitive impairments, in the domains of executive function and some aspects of social cognition, in a large sample 
of non-demented ALS patients. It also further qualified the relationship between social cognition and executive 
dysfunction in ALS, indicating that impaired performance on at least some social cognition tasks in people with ALS 
may be attributable primarily to the executive components of those tasks. More research is needed to substantiate this 
claim. It is possible that more marked impairments in social cognition, less linked to executive processes, may not 
emerge until pathological FTD-like progression.  Longitudinal study with evidence for the progression of FTD-like social 
cognition impairments in ALS patients would provide further support for a cognitive continuum between ALS and FTD. 
 
Acknowledgements 
We thank the patients with ALS who participated in the research. In addition to the listed authors, we thank the following 
individuals who made a significant contribution to the work reported in this paper: Dr Rachael Burman; Catherine 
Knights; Andrew Dougherty; Dr Naomi Martin; Rachel Tuck; Dr Robin Howard; Jan Clarke; Christine Batts; Hazel 
Watts; Joanna Sasson; Helen Copesy; Trish Cutts; Lucy Adamzyck. This study was funded by the Medical Research 
Council; The National Institute of Health Research (NIHR) Dementias and Neurodegenerative Diseases Research 
Network; the Motor Neurone Disease Association. The work leading up to this publication was funded by the European 
11 
 
Community’s Health Seventh Framework Programme (AAC & CES, grant number 259867). AAC & CES are involved 
in two EU Joint Programmes - Neurodegenerative Disease Research (JPND) projects (STRENGTH and ALS-CarE). 
These projects are supported through the following funding organisations under the aegis of JPND - www.jpnd.eu: 
United Kingdom, Medical Research Council and Economic and Social Research Council.  RGB, AAC, CES and LHG 
receive salary support from the NIHR Dementia Biomedical Research Unit and/or the NIHR Biomedical Research 
Centre for Mental Health, both at the South London and Maudsley NHS Foundation Trust and King’s College London. 
The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of 
Health.  
 
Conflict of interest 
The authors declare that they have no conflict of interest.  
 
Ethical Standards 
Ethics approval was obtained from the National Research Ethics South East London Research Ethics Committee 4 
(11/H0807/1). Informed written consent was obtained from all participants. Ethical standards were consistent with the 
1964 Declaration of Helsinki and its later amendments.  
 
References 
1. Goldstein LH, Abrahams S (2013) Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of 
impairment and implications for assessment. Lancet Neurol 12:368-380. doi:10.1016/S1474-4422(13)70026-7 
2. Lillo P, Savage S, Mioshi E et al (2012) Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural 
and cognitive continuum. Amyotroph Lateral Scler 13:102-109. doi: 10.3109/17482968.2011.639376 
3. Lillo P, Mioshi E, Burrell JR et al (2012) Grey and white matter changes across the amyotrophic lateral sclerosis-
frontotemporal dementia continuum. PLoS One 7:e43993. doi: 10.1371/journal.pone.0043993 
4. Raaphorst J, de Visser M, Linssen WH et al (2010) The cognitive profile of amyotrophic lateral sclerosis: A meta-
analysis. Amyotroph Lateral Scler 11:27-37. doi: 10.3109/17482960802645008 
5. Taylor LJ, Brown RG, Tsermentseli S et al (2013) Is language impairment more common than executive dysfunction 
in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 84:494-498. doi: 10.1136/jnnp-2012-303526 
12 
 
6. Witgert M, Salamone AR, Strutt AM et al (2010) Frontal-lobe mediated behavioural dysfunction in amyotrophic 
lateral sclerosis. Eur J Neurol 17:103-110. doi: 10.1111/j.1468-1331.2009.02801.x 
7.  Grossman AB, Levin BE, Bradley WG (2006) Premorbid personality characteristics of patients with ALS. Amyotroph 
Lateral Scler 7:27-31. doi:10.1080/14660820510012004 
8.  Beer JS, Ochsner KN (2006) Social cognition: a multi level analysis. Brain Res 1079:98-105. 
doi:10.1016/j.brainres.2006.01.002 
9. Adolphs R (2009) The social brain: neural basis of social knowledge Annu Rev Psychol 60:693-716. doi: 
10.1146/annurev.psych.60.110707.163514  
10. Elamin M, Pender N, Hardiman O et al (2012) Social cognition in neurodegenerative disorders: a  systematic review. 
J Neurol Neurosurg Psychiatry 83:1071-1079. doi:10.1136/jnnp-2012-302817 
11. Baron-Cohen S, Frith U (1985) Does the autistic child have a "theory of mind"? Cognition 21:37-46. doi: 
10.1016/0010-0277(85)90022-8 
12. Zimmerman EK, Eslinger PJ, Simmons Z et al (2007) Emotional perception deficits in amyotrophic lateral sclerosis. 
Cogn Behav Neurol 20:79-82. doi: 10.1097/WNN.0b013e31804c700b 
13. Girardi A, MacPherson SE, Abrahams S (2011) Deficits in Emotional and Social Cognition in Amyotrophic Lateral 
Sclerosis. Neuropsychology 25:53-65. doi: 10.1037/a0020357 
14. Papps B, Abrahams S, Wicks P, Leigh PN , Goldstein LH (2005) Changes in memory for emotional material in 
amyotrophic lateral sclerosis (ALS). Neuropsychologia 43:1107-1114. doi: 10.1016/j.neuropsychologia.2004.11.027 
15. Staios M, Fisher F, Lindell AK et al (2013) Exploring sarcasm detection in amyotrophic lateral sclerosis using 
ecologically valid measures. Front Hum Neurosci 7:178. doi: 10.3389/fnhum.2013.00178 
16. Savage SA, Lillo P, Kumfor F et al (2014) Emotion processing deficits distinguish pure amyotrophic lateral sclerosis 
from frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener 15:39-46. 
doi:10.3109/21678421.2013.809763 
17. Abrahams S (2011) Social cognition in amyotrophic lateral sclerosis. Neurodegener Dis Manag 1:397-405. 
doi:10.2217/nmt.11.54 
18. Gibbons Z, Snowden JS, Thompson JC et al (2007) Inferring thought and action in motor neurone disease.   
Neuropsychologia 45:1196-1207. doi:10.1016/j.neuropsychologia.2006.10.008 
13 
 
19. Cerami C, Dodich A, Canessa N et al (2013) Emotional empathy in amyotrophic lateral sclerosis: a behavioural and 
voxel-based morphometry study. Amyotroph Lateral Scler Frontotemporal Degener 15:21-29. doi: 
10.3109/21678421.2013.785568 
20. Meier SL, Charleston AJ, Tippett LJ (2010) Cognitive and behavioural deficits associated with the orbitomedial 
prefrontal cortex in amyotrophic lateral sclerosis. Brain 133:3444-3457. doi: 10.1093/brain/awq254 
21. van der Hulst E-J, Bak TH, Abrahams S (2014) Impaired affective and cognitive theory of mind and behavioural 
change in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry Published Online First: 4 December 2014. 
doi:10.1136/jnnp-2014-309290 
22. Cavallo M, Adenzato M, Macpherson SE et al (2011) Evidence of social understanding impairment in patients with 
amyotrophic lateral sclerosis. PLoS One 6:e25948. doi: 10.1371/journal.pone.0025948 
23. Brooks BR, Miller RG, Swash M et al (2000) World Federation of Neurology Research Group on Motor Neuron 
Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral 
Scler Other Motor Neuron Disord 1:293-299. doi:10.1080/146608200300079536 
24. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545. 
25. Holdnack J (2001) Wechsler Test of Adult Reading. Psychological Corporation, San Antonio, Texas 
26. Wechsler D (1999) Wechsler Abbreviated Scale of Intelligence. Psychological Corporation, San Antonio, Texas 
27. Gibbons CJ, Mills RJ, Thornton EW et al (2011) Rasch analysis of the hospital anxiety and depression scale (HADS) 
for use in motor neurone disease. Health Qual Life Outcomes 9:82. doi: 10.1186/1477-7525-9-82 
28. Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that 
incorporates assessments of respiratory function. J Neurol Sci 169:13-21. doi:10.1016/S0022-510X(99)00210-5 
29. Baron-Cohen S, Wheelwright S, Hill J et al (2001) The “Reading the Mind in the Eyes” Test Revised Version: A 
study with normal adults, and adults with asperger syndrome or high-functioning autism. J Child Psychol Psychiatry 
42:241-251. doi: 10.1111/1469-7610.00715 
30. McDonald S, Flanagan S, Rollins JB (2002) The Awareness of Social Inference Test (TASIT). Thames Valley Test 
Company, St Edmonds, UK 
31. Happé F, Brownell H, Winner E (1999) Acquired `theory of mind' impairments following stroke. Cognition 70:211-
240. doi:10.1016/S0010-0277(99)00005-0  
14 
 
32. Delis D, Kaplan E, Krammer J (2001) Delis- Kaplan Executive Function System. Psychological Corporation, San 
Antonio 
33. Abrahams S, Leigh PN, Harvey A et al (2000) Verbal fluency and executive dysfunction in amyotrophic lateral 
sclerosis (ALS). Neuropsychologia 38:734-747. doi:10.1016/S0028-3932(99)00146-3 
34. Burgess PW, Shallice T (1997) The Hayling and Brixton Tests. Thames Valley Company, Bury St Edmonds, UK 
35. Grace J, Malloy P (2001) Frontal Systems Behavioural Scale (FrSBe). Psychological Assessment Resources Inc, 
Lutz, FL 
36. Davis M (1980) A multidimensional approach to individual differences in empathy. JSAS Catalog of Selected 
Documents in Psychology 10, 113-126. doi:10.1037/0022-3514.44.1.113 
37. Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN (1999) The emotional lability questionnaire: a new 
measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci, 169:22-25.  
38. Costa PT, McCrae RR (1992) The Revised NEO Personal Inventory (NEO PI-R) and NEO Five-Factor Inventory 
(NEO-FFI) Proffessional Manual. Psychological Assessment Resources, Inc., Florida, USA 
39. Leys C, Ley C, Klein O et al (2013) Detecting outliers: Do not use standard deviation around the mean, use absolute 
deviation around the median. J Exp Soc Psychol 49:764-766. doi:10.1016/j.jesp.2013.03.013 
40. D'Agostino RB, Belanger A, D'Agostino, RB Jr. (1990) A Suggestion for Using Powerful and Informative Tests of 
Normality. Am Stat 44:316-321. doi: 10.2307/2684359 
41. Royston JP (1983) Some Techniques for Assessing Multivarate Normality Based on the Shapiro- Wilk W. Appl Stat-
J Roy STC 32:121-133. doi: 10.2307/2347291 
42. R Core Team (2015) R: A language and environment for statistical computing. R Foundation for Statistical 
Computing, Vienna, Austria. URL http://www.R-project.org/.  
43. IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp 
44. Strong MJ, Grace GM, Freedman M et al (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and 
behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:131-146. doi: 
10.1080/17482960802654364 
45. Snowden JS, Austin NA, Sembi S et al (2008) Emotion recognition in Huntington's disease and frontotemporal 
dementia. Neuropsychologia 46:2638-2649. doi:10.1016/j.neuropsychologia.2008.04.018 
15 
 
46. Rascovsky K, Hodges JR, Kipps CM et al (2007) Diagnostic criteria for the behavioural variant of frontotemporal 
dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord 21:S14-18. doi: 
10.1097/WAD.0b013e31815c3445 
47. Eslinger PJ, Moore P, Anderson C et al (2011) Social cognition, executive functioning, and neuroimaging correlates 
of empathic deficits in frontotemporal dementia. J Neuropsychiatry Clin Neurosci 23:74-82. doi: 
10.1176/jnp.23.1.jnp74 
48. Kipps CM, Nestor PJ, Acosta-Cabronero J et al (2009) Understanding social dysfunction in the behavioural variant of 
frontotemporal dementia: the role of emotion and sarcasm processing. Brain 132:592-603. doi:10.1093/brain/awn314 
49. McCrae R, John O (1992) An introduction to the five-factor model and its applications. J Pers 60:175-215. doi: 
10.1111/j.1467-6494.1992.tb00970.x 
50. Martin I, McDonald S (2003) Weak coherence, no theory of mind, or executive dysfunction? Solving the puzzle of 
pragmatic language disorders. Brain Lang 85:451-466. doi:10.1016/S0093-934X(03)00070-1 
51. Kaiser NC, Lee GJ, Lu PH et al (2013) What dementia reveals about proverb interpretation and its neuroanatomical 
correlates. Neuropsychologia 51:1726-1733. doi: 10.1016/j.neuropsychologia.2013.05.021 
52. Papagno C, Genoni A (2004) The role of syntactic competence in idiom comprehension: a study on aphasic patients. 
J Neurolinguistics 17:371-382. doi:10.1016/j.jneuroling.2003.11.002 
53. Abrahams S, Newton J, Niven E et al (2014) Screening for cognition and behaviour changes in ALS. Amyotroph 
Lateral Scler Frontotemporal Degener 15:9-14. doi: 10.3109/21678421.2013.805784 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
Table 1 Descriptions of tasks and questionnaires 
Task or Questionnaire                 Description  
Reading the Mind in 
the Eyes (RME) [29] 
 
 
The Awareness of 
Social Inference Test 
(TASIT) [30] 
 
 
 
 
 
 
 
 
 
Happé Cartoon and 
Scenarios [31] 
 
 
 
 
 
Card Sorting 
 
 
 
 
 
Verbal fluency index 
(VFI) [33] 
Participants are presented with images of faces showing only the eye region. They 
must select one out of four words (e.g. ‘playful’, ‘serious’, ‘reflective’, ‘impatient’) 
which they believe best describes the mental or emotional state of the presented face.  
 
Participants are presented with enacted vignettes of everyday social interactions. In the 
Emotion Recognition (ER) condition, actors enact ambiguous dialogue using dynamic 
emotion expression (Happy, Surprised, Sad, Angry, Anxious, Revolted, Neutral).   
Participants must identify the emotions of the actors.  In the Social Inference–Minimal 
(SI-M) and Social Inference-Enriched (SI-E) conditions, actors portray everyday 
conversational exchanges making use of paralinguistic information to reveal or conceal 
their intentions and feelings (e.g. sarcasm, white lies). The SI-E condition provides 
additional contextual cues to indicate the true state of affairs (e.g. a visual cue or a 
prologue to the scene).  In both conditions, participants must respond to closed-ended 
questions (requiring ‘yes’, ‘no’ or ‘don’t know’ responses) regarding what actors are 
thinking, feeling, doing and explicitly or implicitly saying. 
 
Participants are presented with humorous cartoons and vignettes depicting social 
situations involving deception, belief, intention and feelings. Participants must describe 
what is humorous about the cartoons and how or what the characters in the vignettes 
are feeling and thinking. In the first cartoon condition, participants are presented with 
single cartoons, while in the second forced-choice condition they are presented with 
two cartoons and asked to choose which of the two is humorous and explain why.  
 
From the Delis-Kaplan Executive Function Scale (D-KEFS) [32]. In the Card Sorting 
condition, participants categorize cards into sorts on the basis of information displayed 
on the cards. This information can be verbal (e.g. words belonging to a category, such 
as animals) or visual (e.g. cards of similar size or shape). In the Description condition, 
participants describe the relationships between cards within each created category.  
 
Participants write down/say as many words as they can beginning with S and four-
letter words beginning with C in five and four minutes respectively. In subsequent 
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 motor control conditions, the participant is timed as they copy/read out these words as 
quickly as they can. Higher scores indicate longer thinking times and worse 
performance. 
 
The Brixton Spatial 
Anticipation Test [34] 
 
 
 
The Frontal Systems 
Behaviour Scale 
(FrSBe)[35] 
 
 
The Interpersonal 
Reactivity Index (IRI) 
[36] 
 
 
 
 
The Emotional 
Lability Questionnaire 
(ELQ) [37] 
 
 
 
The NEO Personality 
Inventory  
(NEOFFI) [38] 
Participants are presented with a booklet of pages showing a sequence of stimuli 
(circles). Each page contains one coloured circle. As the examiner turns the page, the 
position of the coloured circle changes. Participants must determine the position of the 
next coloured circle in an array based on the positions of previous coloured circles.   
 
46 items measure current everyday behavioural aspects of executive function. 
Participants rate the frequency with which they display certain behaviours on a scale of 
1 (almost never) to 5 (almost always). Total and subscale T-scores (Apathy, 
Disinhibition, and Executive Dysfunction) are computed using normative data. A T-
score > 65 indicates clinically relevant symptomatology. 
 
14 items measure empathic behaviour, such as a tendency to assume others’ 
psychological perspective (perspective-taking) and sympathetic feelings towards others 
(empathic concern). Participants endorse whether an item describes them well on a 
scale of 1 (Does not describe me well) to 5 (Describes me very well). Higher scores 
indicate greater levels of empathy.  
 
33 items measure the frequency and severity of incongruous episodes of laughing, 
crying, and smiling. Participants rate how often they experience these episodes on a 
scale of 0 (Never) to 3 (Frequently). Where relevant, participants also endorse the 
nature of these episodes on 4-point Likert scales, where higher scores indicate greater 
levels of perceived emotional lability.   
 
60 items measure five domains of personality (Neuroticism; Extraversion; Openness; 
Agreeableness; Conscientiousness). Participants endorse statements along a 5-point 
scale, ranging from ‘Strongly Disagree’ to ‘Strongly Agree’. T-scores are derived 
using normative data.  
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Table 2 Demographic, IQ and mood measures 
Demographics                           Mean (SD) 
             ALS                         Controls 
Age (years) 
Education (years) 
     60.3 (8.5)                          60.0 (9.7) 
     14.5 (3.5)                          14.5 (2.7) 
                           Median (IQR) 
            ALS                          Controls 
IQ Measures 
Predicted premorbid FSIQ 
 
     112.0 (108.0-116.0) 
 
114.0 (107.0-117.5) 
WASI FSIQ      117.0 (109.0-122.8)           119.0 (112.5-125.0) 
Mood 
 
HADS Anxiety 
HADS Depression 
HADS Total 
    
    
     4.0 (2.0-6.0)                          
     2.0 (1.0-4.0)                      
     6.0 (4.0-10.0)                      
                                             Cases N (%)      
                                    ALS               Controls 
3.0 (2.0-6.0)                 9 (16.4)           6 (12.2)  
  1.0 (0.0-3.5)                 3 (5.5)             0 (0) 
6.0 (3.0-9.0)                 2 (3.6)             0 (0) 
WASI, Wechsler Abbreviated Scale of Intelligence; FSIQ, Full Scale IQ; HADS, Hospital Anxiety and Depression 
Scale (modified; higher scores indicate worse mood). ALS N=55, Controls N=49 for all measures except predicted pre-
morbid FSIQ ALS N=51, Controls N=49; WASI FSIQ, ALS N=48, Controls N=49.  Higher HADS scores indicate 
greater levels of depression or anxiety; ‘caseness’ determined as per revised criteria [27].  
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Table 3 Performance and ratings on measures of executive function, social cognition, behaviour and personality  
Measure (max possible) 
 
Executive function composite 
              Mean (SD)  
ALS                        Controls 
0.5 (1)                      0.0 (0.7) 
Cut-off     ALS No. (%)a      ALS N 
 
1.6             7 (12.7)                  55 
8.6             10 (18.2)                55 
20.7           3 (5.5)                    55            
12.0           2 (3.8)                    53 
47.0           3 (5.7)                    53 
29.5           5 (9.1)                    55 
1.7             4 (7.3)                    55 
11.0           3 (5.5)                    55 
17.0           10 (18.2)                55 
25.0            2 (3.6)                   55                                                            
VFI ‘S’ Trials 
VFI ‘C’ Trials 
5.2 (3.3)                   4.2 (2.1)                  
16 (11.7)                  12.1 (6.6)                  
DKEFS Card Sorting (32) 
DKEFS Card Sorting Description (64) 
6.1 (2.1)                   4.9 (2.3) 
26.6 (10.6)               20.5 (8.4) 
Brixton Errors (55) 18.3 (5.8)                 16.3 (6.4) 
Social cognition composite 0.4 (0.8)                   0.0 (0.7) 
TASIT Emotion Recognition (28) 
TASIT Social Inference-Minimal (60)  
TASIT Social Inference-Enriched (64) 
5.9 (2.5)                   5.3 (2.7) 
10.6 (6.7)                 8.8 (5.6) 
12.7 (6.6)                 12.7 (6.1) 
Happé Single Cartoon (32) 
Happé Cartoon Pairs (30) 
Happé  Scenarios (30) 
RME Errors (36) 
Behaviour and Personality 
12.0 (5.2)                 7.0 (4.7) 
11.6 (4.6)                 8.3 (5.1) 
 9.6 (4)                     7.0 (4.2) 
10.5 (4.8)                  9.9 (4) 
20.6            5 (11.1)                 45 
18.6            0 (0)                      45 
19.1            1 (2.6)                   38 
17.0            7 (13)                    54 
FrSBe Total score 
FrSBe Apathy  
FrSBe Executive Dysfunction  
FrSBe Disinhibition 
NEO-FFI Neuroticism  
NEO-FFI Extraversion  
NEO-FFI Openness  
NEO-FFI Agreeableness  
NEO-FFI Conscientiousness 
IRI Perspective Taking (28) 
IRI Empathic Concern (28) 
ELQ Total Score (93) 
60.1 (14.4)               59.9 (14.1) 
61.1 (15.3)               55.6 (11.8) 
55.8 (12.7)               58.9 (13.3) 
57.3 (12.4)               59.5 (15) 
44.3 (8.9)                 54.1 (9.2) 
50.8 (11.8)               49.0 (10.5) 
50.3 (9.6)                 48.8 (12.3) 
50.4 (11.5)               55.1 (10.6) 
47.3 (11.1)               44.8 (13.9) 
17.0 (5.2)                 18.2 (4.0) 
19.3 (5.3)                 19.2 (4.1) 
7.0 (0.0-20.0)d         0.0 (0.0-5.0)d 
65               15 (29.4)               51 
65               17 (33.3)               51 
65               12 (23.5)               51 
65               12 (23.5)               51 
35/65          8 (15.4) / 0 (0)c     52 
35/65          0 (0) / 4 (7.7)c       52 
35/65          3 (5.8) / 4 (7.7)c    52 
35/65          5 (9.6) / 3 (5.8)c    52 
35/65          4 (7.7) / 2 (3.8)c    52 
10.0            4 (7.3)                   55 
12.0            6 (10.9)                 55            
21.0            13 (23.6)               55 
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Legend (Table 3) 
Higher scores indicate worse performance or greater impairment except for IRI. aNumber and percentage of patients with 
performance or ratings at or below 5th percentile of controls (composites, cognitive tests scores, IRI and ELQ); meeting 
cut-off criteria for clinically relevant behaviour (FrSBe) and ‘extremely high’ or ‘extremely low’ levels of personality 
trait (NEO-FFI). bMeans derived from untransformed data.  c35 = cut-off for ‘extremely low’, 65 = cut-off for ‘extremely 
high’. dMedian (IQR). VFI, Verbal Fluency Index; DKEFS, Delis-Kaplan Executive Function Scale; TASIT, The 
Awareness of Social Inference Test; RME, Reading the Mind in the Eyes; FrSBe, Frontal Systems Behaviour Scale; 
NEO-FFI, Neo-Five-Factory Inventory; IRI, Interpersonal Reactivity Index; ELQ, Emotional Lability Questionnaire.  
Control N=49 for all measures except: Happé Cartoons, N=48; Happé Scenarios, N=45; FrSBe, N=48; NEO-FFI, N=48. 
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Supplementary material. 
 
Executive dysfunction predicts social cognition impairment in amyotrophic lateral sclerosis 
Journal of Neurology 
Tamlyn J Watermeyer , Richard G Brown, Katie C L Sidle, David J Oliver, Christopher Allen, Joanna Karlsson, 
Catherine M Ellis, Christopher E Shaw, Ammar Al-Chalabi, Laura H Goldstein  (correspondence: 
laura.goldstein@kcl.ac.uk. Institute of Psychiatry, Psychology & Neuroscience, King’s College London) 
 
Table S1: Language: Graded Naming Test (GNT)1 
Between-group 
comparison 
 
Median (IQR) X2 (df) p φc 95% CI 
 ALS 
(n=55) 
HC 
(n=49) 
 
    
GNT (max 30) 23 (14-29) 24 (22-26) 0.6 (1) .44 .08 -1.0;  2.0 
p–values from Medians test. Note: Higher score indicates better performance for group–level analysis; φc, Cramer’s V; 
95% CI, confidence interval for difference between medians 
 
Table S2: Memory: California Verbal Learning Test (CVLT)2 
Between-group 
comparison 
 
Mean (SD)  t(df) p d 95% CI 
Standardized 
scores  
(min-5; max 5) 
 
 ALS 
(n=51) 
HC 
(n=49) 
    
Immediate free  
recall ** 
 
Short delay free 
recall 
 
Long delay free 
recall 
 
Long delay cued  
recall 
50.1 (12.4) 
 
0.1 (1.3) 
 
0.04 (1) 
 
-0.2 (1) 
53.6 (11.5) 
 
0.1 (1.3) 
 
0.2 (0.9) 
 
0.2 (1) 
1.3 (98) 
 
2.5 (98) 
 
1.0 (98) 
 
1.7 (98) 
.20 
 
.80 
 
.31 
 
.09 
-0.29 
 
 0.07 
 
-0.17 
 
-0.37 
-1.7; 8.6 
 
-0.4; 0.6 
 
-0.2; 0.6 
 
-0.1; 0.7 
 
p–values from two–tailed t–tests.** T–score (min 5; max 95); d, Cohen’s d; 95% CI, confidence interval for difference 
between means. Note: Higher score indicates better performance for recall trials.  
 
1. McKenna, P., & Warrington, E. K. (1983). The Graded Naming Test. Cambridge, UK: Cambridge 
Cognition Limited 
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2. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). California Verbal Learning Test: 
Second Edition. San Antonio, TX: Psychological Corporation. 
Table S3. Correlations between potential predictor variables and Social Cognition composite 
 
Potential predictors r (p) 
Demographic variables 
Age 
Education 
 
                    0.44 (.001) 
                   -0.29 (.03) 
Disease factors 
Symptom onset (bulbar/Spinal) 
ALSFRS-R Total score 
ALSFRS-R Bulbar score* 
ALSFRS-R Limb score* 
ALSFRS-R Respiratory score* 
Disease progression rate** 
 
-0.17 (0.22) 
 0.07 (0.63) 
-0.16 (0.25) 
 0.13 (0.33) 
 0.08 (0.55) 
-0.02 (0.88) 
Mood 
HADS Anxiety  
HADS Depression  
HADS Total  
 
-0.26 (0.06) 
-0.24 (0.08) 
-0.27 (0.05) 
Behaviour 
FrSBe Total 
ELQ Total   
NEOFFI Neuroticism 
NEOFFI Extraversion 
NEOFFI Openness 
NEOFFI Agreeableness 
NEOFFI Conscientiousness 
IRI Perspective Taking 
IRI Empathic concern 
 
 0.35 (0.01) 
-0.07 (0.63) 
 0.06 (0.66) 
 0.07 (0.62) 
-0.32 (0.01) 
-0.07 (0.64) 
 0.18 (0.20) 
 0.11 (0.41) 
 0.04 (0.77) 
Cognition 
Executive function composite 
 
     0.61 (<0.001) 
*ALSFRS–R: bulbar=items 1–3; Limb=items 4–9; respiratory=items 10–12. **Disease progression 
 rate =(48-ALSFRS–R total) /months since symptom onset. ALSFRS-R, Amyotrophic Lateral Sclerosis 
 Rating Scale-Revised; FrSBe, Frontal Systems Behavior Scale; HADS, Hospital Anxiety and Depression 
 Scale (modified);NEOFFI, NEO-Personality Inventory; IRI, Interpersonal Reactivity Index 
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Table S4. Results of hierarchical regression model for Social Cognition composite scores 
Step (Independent 
variable) 
B Standard 
Error B 
Standardized 
Β 
95% CI for B 
1. Constant 
    Age 
    Education (years) 
-1.14 
 0.31 
  -0.05 
0.72 
0.01 
0.02 
 
   0.39* 
-0.29 
-2.6; 0.3 
 0.01; 0.1 
-0.1; -0.01 
2. Constant 
    Age 
    Education (years) 
    FrSBe Total 
    HADS Total 
    NEOFFI Openness 
  -1.03 
   0.02 
  -0.03  
   0.01 
  -0.03         
  -0.01 
0.79 
0.01 
0.03 
0.01 
0.02 
0.01 
 
 0.29 
        -0.17 
 0.23 
        -0.20 
-0.13 
-2.6; 0.6 
 0.001; 0.1 
-0.1; 0.0 
-0.0; 0.0 
-0.1; 0.0 
-0.0; 0.0 
3. Constant 
    Age 
    Education (years) 
    FrSBe Total 
    HADS Total 
    NEOFFI Openness 
    Executive Function 
-0.52 
 0.02 
-0.01 
 0.01 
-0.03 
-0.01 
0.48 
0.69 
0.01 
0.03 
0.01 
0.02 
0.01 
0.12 
 
 0.20 
-0.06 
 0.10 
-0.24 
-0.11 
   0.49* 
-1.9; 0.9 
 0.0; 0.0 
-0.1; 0.4 
-0.0; 0.0 
-0.1; 0.0 
-0.2; 0.0 
 0.2; 0.7 
N=48. Results where p< 0.05 shown in bold. Results where p<.001 in bold*. 1. R2=.240, adjusted R2=.206; 
2.  R2=.330, adjusted R2=.250; 3.  R2 =.516, adjusted  R2=.445. FrSBe, Frontal Systems Behavior Scale; 
HADS, Hospital Anxiety and Depression Scale (modified); NEOFFI, NEO-Personality Inventory. 
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Table 4 Cognitive and behavioural profile of six patients showing two or more impairments on social cognition tasks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEO-FFI: A, Agreeableness; E, Extraversion; O, Openness; C, Conscientiousness 
 
Patient Total 
impairments 
on executive 
function 
tasks 
Total 
impairments 
on social 
cognition 
tasks 
HADS 
A 
score 
HADS 
D 
score 
IRI PT 
impaired 
IRI EC 
impaired 
Apathy 
impaired 
Disinhibition 
impaired 
Executive 
Dysfunction 
impaired 
Very 
High 
NEO-
FFI 
Very 
Low 
NEO-
FFI 
001 1 2 1 3 No No Yes No No A N; E 
002 1 2 1 0 No Yes Yes Yes No E; C No 
003 4 5 0 0 No No No No No A N; O 
004 2 2 3 1 No No Yes No No Did not complete 
 
005 1 3 8 0 No No No Yes No E No 
006 0 3 4 3 No No No No No No No 
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Fig. 1 Mean composite scores. Higher scores indicate greater impairment 
*p < 0.5, Error bars represent back transformed confidence intervals  
 
Fig. 2 ALS group Z-scores for individual components of composites. Higher scores indicate greater impairment. C-
Single, Happé Cartoon Single Inference; C-Pairs, Happé Cartoon Pairs; Scenarios, Happé Social Scenarios; RME, 
Reading the Mind in The Eyes Test; TASIT, The Awareness of Social Inference Test; ER, Emotion Recognition; SI-M, 
Social Inference-Minimal; SI-E, Social Inference-Enriched; DKEFS, Delis-Kaplan Executive Function System; desc., 
description; VFI, Verbal Fluency Index 
*significantly different from the control group.   
 
 
 
 
